Cardiol Therapeutics (CRDL) Other Working Capital Changes (2020 - 2026)

Cardiol Therapeutics has reported Other Working Capital Changes for 7 years, with the latest figure at -$1.0 million in Q1 2026.

• For the quarter ending Q1 2026, Other Working Capital Changes fell 61.12% year-over-year to -$1.0 million; the trailing twelve-month figure through Mar 2026 stood at -$2.0 million (down 1918.87% YoY), and the FY2025 full-year result was $1.3 million, up 766.4% from the prior year.
• Other Working Capital Changes for Q1 2026 stood at -$1.0 million, down from -$624172.7 in the prior quarter.
• The five-year high for Other Working Capital Changes was $937682.1 in Q2 2025, with the low at -$1.0 million in Q1 2026.
• Historically, Other Working Capital Changes has averaged $55922.8 across 5 years, with a median of $210370.7 in 2022.
• The largest YoY upside for Other Working Capital Changes was 893.47% in 2025 against a maximum downside of 316.1% in 2025.
• Cardiol Therapeutics' Other Working Capital Changes stood at $210370.7 in 2022, then jumped by 136.86% to $498294.2 in 2023, then sank by 42.04% to $288835.1 in 2024, then sank by 316.1% to -$624172.7 in 2025, then tumbled by 63.07% to -$1.0 million in 2026.
• The last three Other Working Capital Changes figures came in at -$1.0 million (Q1 2026), -$624172.7 (Q4 2025), and $718302.0 (Q3 2025), per Business Quant data.